1 - 25 of 124 results for author:"Parham P." in Literature citations
Results Customize
› Repeat search in UniProtKB (673)
| Natural selection on marine carnivores elaborated a diverse family of classical MHC class I genes exhibiting haplotypic gene content variation and allelic polymorphism. Hammond J.A., Guethlein L.A., Norman P.J., Parham P. Immunogenetics 64:915-933(2012) · UniProtKB (67) |
| Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. Hilton H.G., Vago L., Older Aguilar A.M., Moesta A.K., Graef T., Abi-Rached L., Norman P.J., Guethlein L.A., Fleischhauer K., Parham P. J. Immunol. 189:1418-1430(2012) · Mapped (276) |
| The shaping of modern human immune systems by multiregional admixture with archaic humans. Abi-Rached L., Jobin M.J., Kulkarni S., McWhinnie A., Dalva K., Gragert L., Babrzadeh F., Gharizadeh B., Luo M., Plummer F.A. et al. Science 334:89-94(2011) · UniProtKB (18) |
| Variable NK cell receptors exemplified by human KIR3DL1/S1. Parham P., Norman P.J., Abi-Rached L., Guethlein L.A. J. Immunol. 187:11-19(2011) · Mapped (1,472) |
| Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. Gleimer M., Wahl A.R., Hickman H.D., Abi-Rached L., Norman P.J., Guethlein L.A., Hammond J.A., Draghi M., Adams E.J., Juo S. et al. J. Immunol. 186:1575-1588(2011) · UniProtKB (1) |
| Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. Pyo C.W., Guethlein L.A., Vu Q., Wang R., Abi-Rached L., Norman P.J., Marsh S.G., Miller J.S., Parham P., Geraghty D.E. PLoS ONE 5:e15115-e15115(2010) · Mapped (31) |
| Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. Taner S.B., Pando M.J., Roberts A., Schellekens J., Marsh S.G., Malmberg K.J., Parham P., Brodsky F.M. J. Immunol. 186:62-72(2011) · Mapped (1,027) |
| Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. Abi-Rached L., Moesta A.K., Rajalingam R., Guethlein L.A., Parham P. PLoS Genet. 6:e1001192-e1001192(2010) · UniProtKB (9) |
| Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. Moesta A.K., Graef T., Abi-Rached L., Older Aguilar A.M., Guethlein L.A., Parham P. J. Immunol. 185:4233-4237(2010) · Mapped (14) |
| KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. Graef T., Moesta A.K., Norman P.J., Abi-Rached L., Vago L., Older Aguilar A.M., Gleimer M., Hammond J.A., Guethlein L.A., Bushnell D.A. et al. J. Exp. Med. 206:2557-2572(2009) · UniProtKB (1) · Mapped (33) |
| Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Gendzekhadze K., Norman P.J., Abi-Rached L., Graef T., Moesta A.K., Layrisse Z., Parham P. Proc. Natl. Acad. Sci. U.S.A. 106:18692-18697(2009) · UniProtKB (1) |
| Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. Sharma D., Bastard K., Guethlein L.A., Norman P.J., Yawata N., Yawata M., Pando M., Thananchai H., Dong T., Rowland-Jones S. et al. J. Immunol. 183:4569-4582(2009) · Mapped (480) |
| Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Norman P.J., Abi-Rached L., Gendzekhadze K., Hammond J.A., Moesta A.K., Sharma D., Graef T., McQueen K.L., Guethlein L.A., Carrington C.V. et al. |
| Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. Hammond J.A., Guethlein L.A., Abi-Rached L., Moesta A.K., Parham P. J. Immunol. 182:3618-3627(2009) · UniProtKB (6) |
| Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Cooley S., Trachtenberg E., Bergemann T.L., Saeteurn K., Klein J., Le C.T., Marsh S.G., Guethlein L.A., Parham P., Miller J.S. et al. Blood 113:726-732(2009) · Mapped (133) |
| Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. Sanjanwala B., Draghi M., Norman P.J., Guethlein L.A., Parham P. J. Immunol. 181:6293-6300(2008) · Mapped (33) |
| Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? Thomas R., Yamada E., Alter G., Martin M.P., Bashirova A.A., Norman P.J., Altfeld M., Parham P., Anderson S.K., McVicar D.W. et al. J. Immunol. 180:6743-6750(2008) · Mapped (31) |
| Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Norman P.J., Abi-Rached L., Gendzekhadze K., Korbel D., Gleimer M., Rowley D., Bruno D., Carrington C.V., Chandanayingyong D., Chang Y.H. et al. Nat. Genet. 39:1092-1099(2007) · UniProtKB (30) · Mapped (35) |
| Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. Guethlein L.A., Older Aguilar A.M., Abi-Rached L., Parham P. J. Immunol. 179:491-504(2007) · UniProtKB (6) |
| Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins. Abi-Rached L., Dorighi K., Norman P.J., Yawata M., Parham P. J. Immunol. 178:7943-7954(2007) · UniProtKB (15) |
| High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Houtchens K.A., Nichols R.J., Ladner M.B., Boal H.E., Sollars C., Geraghty D.E., Davis L.M., Parham P., Trachtenberg E.A. Immunogenetics 59:525-537(2007) · Mapped (2) |
| Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. McQueen K.L., Dorighi K.M., Guethlein L.A., Wong R., Sanjanwala B., Parham P. Hum. Immunol. 68:309-323(2007) · Mapped (35) |
| Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. O'Connor G.M., Guinan K.J., Cunningham R.T., Middleton D., Parham P., Gardiner C.M. J. Immunol. 178:235-241(2007) · Mapped (31) |
| Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P. et al. J. Immunol. 178:33-37(2007) · Mapped (480) |
| The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. Brooks C.R., Elliott T., Parham P., Khakoo S.I. J. Immunol. 176:1141-1147(2006) · Mapped (2) |